Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
54
2024
2915
3.910
Why?
Antibodies, Bispecific
5
2024
70
1.020
Why?
Hematopoietic Stem Cell Transplantation
8
2024
554
1.010
Why?
Leukemia, Plasma Cell
2
2020
33
0.880
Why?
Immunotherapy, Adoptive
5
2024
158
0.730
Why?
Neoplasms, Plasma Cell
3
2024
35
0.650
Why?
Chromosome Deletion
2
2023
138
0.590
Why?
Bone Marrow
9
2022
351
0.580
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.570
Why?
Humans
62
2024
49898
0.560
Why?
Transplantation, Autologous
9
2024
462
0.540
Why?
Clinical Trials as Topic
4
2022
466
0.530
Why?
Tumor Suppressor Protein p53
1
2017
213
0.500
Why?
Proteasome Inhibitors
1
2016
104
0.490
Why?
Immunologic Factors
1
2016
112
0.490
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
111
0.490
Why?
B-Cell Maturation Antigen
6
2024
88
0.480
Why?
Plasma Cells
5
2023
221
0.470
Why?
Immunotherapy
1
2016
235
0.450
Why?
Stem Cell Transplantation
5
2024
179
0.440
Why?
Translocation, Genetic
5
2021
263
0.440
Why?
Antibodies, Monoclonal
2
2022
457
0.430
Why?
Gene Expression Regulation, Neoplastic
5
2021
824
0.420
Why?
Mutation
6
2022
1292
0.410
Why?
Prognosis
13
2024
1956
0.400
Why?
Aged
19
2024
9447
0.400
Why?
Neutropenia
2
2023
114
0.400
Why?
Survival Analysis
8
2024
670
0.390
Why?
Neoplasms
2
2012
1233
0.380
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.380
Why?
Lymphocytes
1
2012
154
0.370
Why?
Gene Expression Profiling
8
2023
1028
0.360
Why?
Cancer Vaccines
1
2011
78
0.360
Why?
Evolution, Molecular
2
2021
97
0.360
Why?
Neoplasm, Residual
5
2022
156
0.350
Why?
Neoplasm Recurrence, Local
6
2024
626
0.330
Why?
Cytokines
1
2012
607
0.320
Why?
Tumor Microenvironment
3
2024
221
0.300
Why?
Hematologic Neoplasms
2
2022
98
0.290
Why?
Neoplasm Proteins
3
2020
321
0.290
Why?
Atrial Fibrillation
2
2022
182
0.280
Why?
Combined Modality Therapy
4
2024
638
0.280
Why?
Female
23
2024
26560
0.270
Why?
Middle Aged
17
2024
12285
0.250
Why?
Aged, 80 and over
7
2024
3136
0.240
Why?
Fluorodeoxyglucose F18
4
2021
189
0.240
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Neoplasms, Second Primary
1
2024
74
0.220
Why?
Treatment Outcome
8
2024
5176
0.220
Why?
Male
21
2024
25437
0.220
Why?
Chromosomes, Human, Pair 1
2
2023
92
0.210
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
994
0.210
Why?
Positron-Emission Tomography
3
2022
286
0.210
Why?
Adult
14
2024
13346
0.210
Why?
Risk Factors
9
2024
3604
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.200
Why?
Paraproteinemias
1
2022
71
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
Osteolysis
1
2022
75
0.200
Why?
Drug Approval
1
2022
47
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.200
Why?
Lymphoma, B-Cell
1
2022
61
0.190
Why?
Epigenomics
1
2021
67
0.190
Why?
Patient Participation
1
2022
67
0.190
Why?
T-Lymphocytes
4
2024
328
0.190
Why?
Diffusion Magnetic Resonance Imaging
2
2019
123
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Cell Cycle
1
2021
226
0.180
Why?
Practice Guidelines as Topic
1
2023
458
0.180
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Disease Progression
5
2021
820
0.170
Why?
Bone Resorption
1
2022
297
0.170
Why?
Bone Diseases
1
2021
97
0.170
Why?
Chromosomal Instability
1
2019
16
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
Antigens, CD
1
2020
215
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
279
0.160
Why?
Spleen
1
2019
170
0.150
Why?
Spinal Fractures
1
2018
37
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Antineoplastic Agents
2
2024
1175
0.150
Why?
Bacteremia
1
2019
90
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Gene Rearrangement
1
2018
73
0.140
Why?
Recurrence
4
2024
658
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Epigenesis, Genetic
1
2020
370
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Pelvis
1
2017
66
0.140
Why?
Cell Proliferation
4
2023
986
0.140
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
103
0.140
Why?
Immunoglobulin Light Chains
1
2017
82
0.140
Why?
Retrospective Studies
6
2024
6123
0.130
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
Gene Expression
1
2018
612
0.130
Why?
Animals
4
2024
13100
0.120
Why?
Cystatin M
2
2024
19
0.110
Why?
Cross-Sectional Studies
3
2023
1573
0.110
Why?
Disease-Free Survival
3
2019
450
0.100
Why?
Survival Rate
3
2020
905
0.100
Why?
Cardiovascular Diseases
1
2017
444
0.100
Why?
Lymphoma, Non-Hodgkin
1
2011
58
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Disease Models, Animal
1
2016
1411
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
256
0.090
Why?
Alleles
2
2021
251
0.090
Why?
Genomics
2
2023
284
0.090
Why?
Tumor Burden
2
2020
131
0.080
Why?
Histones
2
2021
295
0.080
Why?
Vaccination
1
2011
275
0.080
Why?
Transcription Factors
2
2023
565
0.080
Why?
DNA Copy Number Variations
2
2021
108
0.080
Why?
Radiopharmaceuticals
2
2021
204
0.080
Why?
Brain Neoplasms
1
2011
282
0.080
Why?
Models, Biological
1
2011
719
0.080
Why?
Cell Differentiation
2
2022
649
0.070
Why?
Transcriptome
2
2020
312
0.070
Why?
Follow-Up Studies
2
2024
2175
0.070
Why?
Kaplan-Meier Estimate
2
2019
463
0.070
Why?
Imaging, Three-Dimensional
2
2017
152
0.060
Why?
Biopsy
2
2018
591
0.060
Why?
Arkansas
2
2021
1987
0.060
Why?
Killer Cells, Natural
1
2024
107
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Demography
1
2024
93
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
124
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
53
0.060
Why?
Antibodies
1
2024
151
0.050
Why?
Mice
2
2024
5658
0.050
Why?
Signal Transduction
2
2021
1608
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
47
0.050
Why?
Geography
1
2022
61
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Patient Selection
1
2023
254
0.050
Why?
United States Food and Drug Administration
1
2022
91
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Bone Marrow Transplantation
1
2022
112
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Dexamethasone
1
2024
424
0.050
Why?
Chromosome Aberrations
1
2023
295
0.050
Why?
Syndecan-1
1
2021
72
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
84
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Chromatin
1
2021
137
0.050
Why?
Remission Induction
1
2021
205
0.050
Why?
Clone Cells
1
2021
78
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
223
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Pyrimidines
1
2022
192
0.050
Why?
Aneuploidy
1
2020
18
0.050
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Genome, Human
1
2021
110
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Protein Kinase Inhibitors
1
2022
205
0.040
Why?
DNA, Neoplasm
1
2020
145
0.040
Why?
Health Status Disparities
1
2022
196
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
Cell Line, Tumor
1
2023
1388
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
168
0.040
Why?
Osteoclasts
1
2022
424
0.040
Why?
Multivariate Analysis
1
2021
579
0.040
Why?
Computational Biology
1
2020
214
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
27
0.040
Why?
Pseudomonas Infections
1
2019
47
0.040
Why?
Syndrome
1
2019
237
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
424
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Oncogene Proteins, Fusion
1
2018
59
0.040
Why?
Protein-Tyrosine Kinases
1
2018
95
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
False Positive Reactions
1
2017
60
0.040
Why?
Bone and Bones
1
2021
473
0.040
Why?
Glomerular Filtration Rate
1
2017
110
0.040
Why?
Amino Acid Sequence
1
2018
579
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
NF-kappa B
1
2018
315
0.030
Why?
Glycolysis
1
2016
68
0.030
Why?
DNA Methylation
1
2020
544
0.030
Why?
Models, Genetic
1
2016
174
0.030
Why?
Genomic Instability
1
2016
91
0.030
Why?
Staphylococcal Infections
1
2019
269
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Logistic Models
1
2018
895
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
139
0.030
Why?
Heart
1
2017
334
0.030
Why?
Kidney Diseases
1
2017
211
0.030
Why?
Algorithms
1
2018
613
0.030
Why?
Echocardiography
1
2017
381
0.030
Why?
Time Factors
1
2021
2891
0.030
Why?
Myocardium
1
2017
443
0.030
Why?
Disease Management
1
2015
175
0.030
Why?
Longitudinal Studies
1
2016
693
0.030
Why?
Risk Assessment
1
2018
1254
0.030
Why?
Tomography, X-Ray Computed
1
2017
1150
0.020
Why?
United States
1
2022
4878
0.020
Why?
Fatal Outcome
1
2011
194
0.020
Why?
Magnetic Resonance Imaging
1
2017
1525
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description